Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis

被引：49
作者：
Hofbauer, LC
Heufelder, AE
机构：
[1] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA
[2] Univ Munich, Klinikum Innenstadt, Med Klin, Div Endocrinol, D-8000 Munich, Germany
来源：
EUROPEAN JOURNAL OF ENDOCRINOLOGY | 1998年 / 139卷 / 02期
关键词：
D O I：
10.1530/eje.0.1390152
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 154
页数：3
相关论文
共 11 条
  • [1] ANDERSON MA, 1997, NATURE, V390, P175
  • [2] Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    Lacey, DL
    Timms, E
    Tan, HL
    Kelley, MJ
    Dunstan, CR
    Burgess, T
    Elliott, R
    Colombero, A
    Elliott, G
    Scully, S
    Hsu, H
    Sullivan, J
    Hawkins, N
    Davy, E
    Capparelli, C
    Eli, A
    Qian, YX
    Kaufman, S
    Sarosi, I
    Shalhoub, V
    Senaldi, G
    Guo, J
    Delaney, J
    Boyle, WJ
    [J]. CELL, 1998, 93 (02) : 165 - 176
  • [3] Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts
    Miyamoto, A
    Kunisada, T
    Hemmi, H
    Yamane, T
    Yasuda, H
    Miyake, K
    Yamazaki, H
    Hayashi, SI
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (03) : 703 - 709
  • [4] Bone and the hematopoietic and immune systems: A report of the proceedings of a scientific workshop
    Sharrock, WJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (04) : 537 - 543
  • [5] Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
    Simonet, WS
    Lacey, DL
    Dunstan, CR
    Kelley, M
    Chang, MS
    Luthy, R
    Nguyen, HQ
    Wooden, S
    Bennett, L
    Boone, T
    Shimamoto, G
    DeRose, M
    Elliott, R
    Colombero, A
    Tan, HL
    Trail, G
    Sullivan, J
    Davy, E
    Bucay, N
    RenshawGegg, L
    Hughes, TM
    Hill, D
    Pattison, W
    Campbell, P
    Sander, S
    Van, G
    Tarpley, J
    Derby, P
    Lee, R
    Boyle, WJ
    [J]. CELL, 1997, 89 (02) : 309 - 319
  • [6] Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells
    Tan, KB
    Harrop, J
    Reddy, M
    Young, P
    Terrett, J
    Emery, J
    Moore, G
    Truneh, A
    [J]. GENE, 1997, 204 (1-2) : 35 - 46
  • [7] Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
    Tsuda, E
    Goto, M
    Mochizuki, S
    Yano, K
    Kobayashi, F
    Morinaga, T
    Higashio, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (01) : 137 - 142
  • [8] TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
    Wong, BR
    Rho, JR
    Arron, J
    Robinson, E
    Orlinick, J
    Chao, M
    Kalachikov, S
    Cayani, E
    Bartlett, FS
    Frankel, WN
    Lee, SY
    Choi, YW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) : 25190 - 25194
  • [9] Characterization of structural domains of human osteoclastogenesis inhibitory factor
    Yamaguchi, K
    Kinosaki, M
    Goto, M
    Kobayashi, F
    Tsuda, E
    Morinaga, T
    Higashio, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) : 5117 - 5123
  • [10] Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG):: A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
    Yasuda, H
    Shima, N
    Nakagawa, N
    Mochizuki, SI
    Yano, K
    Fujise, N
    Sato, Y
    Goto, M
    Yamaguchi, K
    Kuriyama, M
    Kanno, T
    Murakami, A
    Tsuda, E
    Morinaga, T
    Higashio, K
    [J]. ENDOCRINOLOGY, 1998, 139 (03) : 1329 - 1337
12